Status
Conditions
Treatments
About
This clinical study aims to evaluate the effectiveness and safety of zygomatic implants placed using dynamic navigation technology. Specifically, it compares two types of zygomatic implants with different surface characteristics: one with a fully rough surface and another with a partially smooth (machined) surface near the gum line. The goal is to determine whether surface design affects surgical performance, healing, implant success, and patient outcomes. A total of 22 patients with severe upper jaw bone loss will receive both types of implants-one on each side of the upper jaw-in a randomized, split-mouth design. The study also evaluates pain, swelling, healing time, and patient quality of life over a 5-year follow-up period.
Full description
This prospective, randomized, split-mouth clinical study investigates the use of dynamic navigation for the placement of zygomatic implants in patients with severely atrophic maxillae. The primary aim is to compare two different surface configurations of zygomatic implants: a fully rough surface versus a partially machined (smooth) coronal surface. Each of the 22 enrolled patients will receive both implant types-one per side-allowing for direct intra-patient comparison.
All surgeries are planned using three-dimensional imaging and performed with a dynamic navigation system (ImplaNav), calibrated for the longer drills required for zygomatic implant sites. The study evaluates surgical accuracy, implant stability, preparation time, postoperative pain and swelling, sinus membrane response, and long-term implant and prosthetic success. Patient quality of life is also monitored over a 5-year follow-up using standardized questionnaires and radiographic assessments.
This study aims to provide evidence on whether implant surface design influences clinical performance and healing outcomes in zygomatic implant rehabilitation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients requiring partial or full rehabilitation of the atrophic maxilla
Candidates for placement of at least one zygomatic implant per side (right and left), connected to at least one standard or zygomatic implant
Severe maxillary atrophy confirmed by CT scan, with insufficient bone for conventional implants or only sufficient bone for 2 frontal implants (minimum diameter 3.5 mm, length 8 mm)
Residual alveolar crest height ≤ 4 mm beneath the maxillary sinus
Age ≥ 18 years
Signed informed consent
Exclusion criteria
General contraindications to oral surgery
History of radiation therapy to the head and neck exceeding 70 Gy
Compromised or suppressed immune system
Current or past use of intravenous bisphosphonates
Uncontrolled diabetes mellitus
Alcohol or drug dependency
Psychiatric disorders
Pregnancy or breastfeeding
Participation in other clinical trials
Inability to attend a 5-year follow-up
Limited mouth opening (< 3.5 cm interincisal distance)
Absence of opposing dentition or lower prosthesis
Acute or chronic infection in the intended implant site
Untreated active periodontal disease
Poor oral hygiene motivation
Radiographic signs of sinus membrane inflammation or ostium obstruction
Primary purpose
Allocation
Interventional model
Masking
22 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal